Tagged With "Montelukast"

The U.S. Food and Drug Administration today announced that it is requiring a boxed warning – the agency’s most prominent warning – for montelukast (sold under the brand name Singulair and in generic form) to strengthen an existing warning about the risk of neuropsychiatric events associated with the drug, which is used to treat asthma and allergic rhinitis (hay fever).

Hi, Thank-you for sending the info. on Singular!! I had told one Dr. many years ago, that it was causing insomnia, and the dosage was too high. I had asked for a children's dosage,but she said , "No, the insurance would not cover it". I quit taking it. Sincerely, Terri

Wow! This is frightening! I will be talking to our allergist about taking my son off of this medication.